MedTrace Logo

Amygdala MRI-TIS for Depression

NCT06461260 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-06-14

No results posted yet for this study

Summary

The study utilizes a non-invasive deep brain stimulation (temporal interference, TI) technique primarily targeting the amygdala to preliminarily explore the clinical efficacy and potential mechanisms of MRI-compatible TI technology in regulating the amygdala in depressive disorders, providing a more comprehensive basis for the application of TI technology.

Conditions

Interventions

DEVICE

Nervio-X

An 8-channel TIS device developed by NEURODOME Corporation.

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-27
Primary Completion
2025-04-28
Completion
2025-04-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06461260 on ClinicalTrials.gov